Trial Profile
A multicentre, non- randomized, prospective, cohort study investigated the efficacy and safety of Sorafenib compared with hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Cisplatin; Fluorouracil
- Indications Liver cancer
- Focus Therapeutic Use
- 08 Mar 2016 New trial record